BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21620768)

  • 1. Regulatory T cells: stability revisited.
    Bailey-Bucktrout SL; Bluestone JA
    Trends Immunol; 2011 Jul; 32(7):301-6. PubMed ID: 21620768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of FOXP3
    Mohr A; Atif M; Balderas R; Gorochov G; Miyara M
    Clin Exp Immunol; 2019 Jul; 197(1):24-35. PubMed ID: 30830965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation and function of Foxp3(+) effector regulatory T cells.
    Cretney E; Kallies A; Nutt SL
    Trends Immunol; 2013 Feb; 34(2):74-80. PubMed ID: 23219401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilizing human regulatory T cells for tolerance inducing immunotherapy.
    He X; Koenen HJ; Slaats JH; Joosten I
    Immunotherapy; 2017 Aug; 9(9):735-751. PubMed ID: 28771099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cell plasticity: beyond the controversies.
    Hori S
    Trends Immunol; 2011 Jul; 32(7):295-300. PubMed ID: 21636323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier.
    Esensten JH; Muller YD; Bluestone JA; Tang Q
    J Allergy Clin Immunol; 2018 Dec; 142(6):1710-1718. PubMed ID: 30367909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases.
    Papotto PH; Reinhardt A; Prinz I; Silva-Santos B
    J Autoimmun; 2018 Feb; 87():26-37. PubMed ID: 29203226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foxp3, Regulatory T Cell, and Autoimmune Diseases.
    Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP
    Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease.
    Leung S; Liu X; Fang L; Chen X; Guo T; Zhang J
    Cell Mol Immunol; 2010 May; 7(3):182-9. PubMed ID: 20383174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance of regulatory T cells in human autoimmune diseases.
    Dejaco C; Duftner C; Grubeck-Loebenstein B; Schirmer M
    Immunology; 2006 Mar; 117(3):289-300. PubMed ID: 16476048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Family of IL-10-secreting CD4+ T cells.
    Fujio K; Okamura T; Yamamoto K
    Adv Immunol; 2010; 105():99-130. PubMed ID: 20510731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose interleukin-2 promotes STAT-5 phosphorylation, T
    Jeffery HC; Jeffery LE; Lutz P; Corrigan M; Webb GJ; Hirschfield GM; Adams DH; Oo YH
    Clin Exp Immunol; 2017 Jun; 188(3):394-411. PubMed ID: 28176332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy: HSCT-resetting immune tolerance by boosting TREG cell diversity.
    Duarte JH
    Nat Rev Rheumatol; 2015 Dec; 11(12):681. PubMed ID: 26526646
    [No Abstract]   [Full Text] [Related]  

  • 14. The progress and prospect of regulatory T cells in autoimmune diseases.
    Zhang X; Olsen N; Zheng SG
    J Autoimmun; 2020 Jul; 111():102461. PubMed ID: 32305296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of human FoxP3
    Attias M; Al-Aubodah T; Piccirillo CA
    Clin Exp Immunol; 2019 Jul; 197(1):36-51. PubMed ID: 30864147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis.
    Miao J; Zhu P
    Curr Rheumatol Rep; 2018 Apr; 20(5):30. PubMed ID: 29663162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity.
    Jaeckel E; Kretschmer K; Apostolou I; von Boehmer H
    Semin Immunol; 2006 Apr; 18(2):89-92. PubMed ID: 16473523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treg cells in autoimmunity: from identification to Treg-based therapies.
    Göschl L; Scheinecker C; Bonelli M
    Semin Immunopathol; 2019 May; 41(3):301-314. PubMed ID: 30953162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced killing activity of regulatory T cells ameliorates inflammation and autoimmunity.
    Askenasy N
    Autoimmun Rev; 2013 Aug; 12(10):972-5. PubMed ID: 23684702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.